UB Paderborn / Katalog / Suche / in CDI

1 – 14 von 14

Sortiert nach

CYP2B6 Genotype‐Dependent Inhibition of CYP1A2 and Induction of CYP2A6 by the Antiretroviral Drug Efavirenz in Healthy Volunteers

Clinical and translational science, 2019-11, Vol.12 (6), p.657-666

2019

Volltextzugriff (PDF)

Methadone adverse reaction presenting with large increase in plasma methadone binding: a case series

Journal of medical case reports, 2011-10, Vol.5 (1), p.513-513, Article 513

2011

Volltextzugriff (PDF)

Inhibition of platelet aggregation by prostaglandin E1 (PGE1) in diabetic patients during therapy with clopidogrel and aspirin

Platelets (Edinburgh), 2013-01, Vol.24 (2), p.145-150

2013

Volltextzugriff (PDF)

Platelet factor XIIIa release during platelet aggregation and plasma clot strength measured by thrombelastography in patients with coronary artery disease treated with clopidogrel

Platelets (Edinburgh), 2015-01, Vol.26 (4), p.358-363

2015

Volltextzugriff (PDF)

Protease activated receptor-1 (PAR-1) mediated platelet aggregation is dependant on clopidogrel response

Thrombosis research, 2012-08, Vol.130 (2), p.198-202

2012

Volltextzugriff (PDF)

Morbid obesity and metabolic syndrome in Ossabaw miniature swine are associated with increased platelet reactivity

Diabetes, metabolic syndrome and obesity, 2011-01, Vol.4 (default), p.99-105

2011

Volltextzugriff (PDF)

Cytochrome P450 3A422, PPAR-α, and ARNT polymorphisms and clopidogrel response

Clinical pharmacology: advances and applications, 2013-01, Vol.5 (Issue 1), p.185-192

2013

Volltextzugriff (PDF)

Platelet function measured by VerifyNow™ identifies generalized high platelet reactivity in aspirin treated patients

Platelets (Edinburgh), 2007-01, Vol.18 (6), p.414-423

2007

Volltextzugriff (PDF)

Cytochrome P450 3A422, PPAR-[alpha], and ARNT polymorphisms and clopidogrel response.(ORIGINAL RESEARCH)(Ah-receptor nuclear translocator)(peroxisome proliferator-activated receptor-[alpha])

Clinical pharmacology: advances and applications, 2013-01, Vol.5, p.185

2013

Volltextzugriff (PDF)

Influence of paraoxonase-1 Q192R and cytochrome P450 2CI9 polymorphisms on clopidogrel response.(ORIGINAL RESEARCH)

Clinical pharmacology: advances and applications, 2012-01, Vol.4, p.13

2012

Volltextzugriff (PDF)

Protease activated receptor-1 (PAR-1) mediated platelet aggregation is dependent on clopidogrel response

Thrombosis research, 2012-08, Vol.130 (2), p.198-202

2012

Volltextzugriff (PDF)

Muskelin regulates actin-dependent synaptic changes and intrinsic brain activity relevant to behavioral and cognitive processes

Communications biology, 2022-06, Vol.5 (1), p.589-589, Article 589

2022

Volltextzugriff (PDF)

Phosphoproteomics identifies dual-site phosphorylation in an extended basophilic motif regulating FILIP1-mediated degradation of filamin-C

Communications biology, 2020-05, Vol.3 (1), p.253, Article 253

2020

Volltextzugriff (PDF)

Membrane microviscosity does not correlate with blood pressure: a cosegregation study

Journal of hypertension, 1993-01, Vol.11 (1), p.25-30

1993

Volltextzugriff (PDF)

1 – 14 von 14

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(14)
Mit Volltextzugriff
(14)

Publikationsform

Artikel
(14)

Sprache

Englisch
(14)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(9)
Science & Technology
(9)
Clopidogrel
(7)
Female
(5)
Male
(5)
Hematology
(4)
Humans
(4)
Middle Aged
(4)
Platelet Aggregation - Drug Effects
(4)
Aged
(3)
Cell Biology
(3)
Cytochrome P-450
(3)
Genetic Aspects
(3)
Health Aspects
(3)
Platelet
(3)
Ticlopidine - Analogs & Derivatives
(3)
Ticlopidine - Therapeutic Use
(3)
Actin
(2)
Adenosine Diphosphate - Pharmacology
(2)
Aggregation
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

CYP2B6 Genotype‐Dependent Inhibition of CYP1A2 and Induction of CYP2A6 by the Antiretroviral Drug Efavirenz in Healthy Volunteers

Methadone adverse reaction presenting with large increase in plasma methadone binding: a case series

Inhibition of platelet aggregation by prostaglandin E1 (PGE1) in diabetic patients during therapy with clopidogrel and aspirin

Platelet factor XIIIa release during platelet aggregation and plasma clot strength measured by thrombelastography in patients with coronary artery disease treated with clopidogrel

Protease activated receptor-1 (PAR-1) mediated platelet aggregation is dependant on clopidogrel response

Morbid obesity and metabolic syndrome in Ossabaw miniature swine are associated with increased platelet reactivity

Cytochrome P450 3A422, PPAR-α, and ARNT polymorphisms and clopidogrel response

Platelet function measured by VerifyNow™ identifies generalized high platelet reactivity in aspirin treated patients

Cytochrome P450 3A422, PPAR-[alpha], and ARNT polymorphisms and clopidogrel response.(ORIGINAL RESEARCH)(Ah-receptor nuclear translocator)(peroxisome proliferator-activated receptor-[alpha])

Influence of paraoxonase-1 Q192R and cytochrome P450 2CI9 polymorphisms on clopidogrel response.(ORIGINAL RESEARCH)

Protease activated receptor-1 (PAR-1) mediated platelet aggregation is dependent on clopidogrel response

Muskelin regulates actin-dependent synaptic changes and intrinsic brain activity relevant to behavioral and cognitive processes

Phosphoproteomics identifies dual-site phosphorylation in an extended basophilic motif regulating FILIP1-mediated degradation of filamin-C

Membrane microviscosity does not correlate with blood pressure: a cosegregation study

Aktive Filter

Suchergebnisse filtern